Clinical Trial Update: The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating MRI-based assessment of doxorubicin-induced cardiotoxicity in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: University of Miami | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED